510 related articles for article (PubMed ID: 16227250)
1. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.
Bukreyev A; Huang Z; Yang L; Elankumaran S; St Claire M; Murphy BR; Samal SK; Collins PL
J Virol; 2005 Nov; 79(21):13275-84. PubMed ID: 16227250
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins.
Skiadopoulos MH; Surman SR; Riggs JM; Orvell C; Collins PL; Murphy BR
Virology; 2002 May; 297(1):136-52. PubMed ID: 12083844
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
[TBL] [Abstract][Full Text] [Related]
4. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
[TBL] [Abstract][Full Text] [Related]
5. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
Kim SH; Samal SK
Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
[TBL] [Abstract][Full Text] [Related]
6. Recombinant-attenuated
Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
[TBL] [Abstract][Full Text] [Related]
7. Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.
Mason JN; Elbahesh H; Russell CJ
J Virol; 2013 May; 87(10):5959-69. PubMed ID: 23514887
[TBL] [Abstract][Full Text] [Related]
8. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
9. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
[TBL] [Abstract][Full Text] [Related]
10. Recombinant duck enteritis viruses expressing the Newcastle disease virus (NDV) F gene protects chickens from lethal NDV challenge.
Ding L; Chen P; Bao X; Li A; Jiang Y; Hu Y; Ge J; Zhao Y; Wang B; Liu J; Chen H
Vet Microbiol; 2019 May; 232():146-150. PubMed ID: 31030839
[TBL] [Abstract][Full Text] [Related]
11. Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein.
Cosset FL; Bouquet JF; Drynda A; Chebloune Y; Rey-Senelonge A; Kohen G; Nigon VM; Desmettre P; Verdier G
Virology; 1991 Dec; 185(2):862-6. PubMed ID: 1660204
[TBL] [Abstract][Full Text] [Related]
12. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.
Kumar S; Nayak B; Collins PL; Samal SK
J Virol; 2011 Jul; 85(13):6521-34. PubMed ID: 21525340
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.
Durbin AP; Wyatt LS; Siew J; Moss B; Murphy BR
Vaccine; 1998 Aug; 16(13):1324-30. PubMed ID: 9682397
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
[TBL] [Abstract][Full Text] [Related]
16. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
Nagy E; Krell PJ; Dulac GC; Derbyshire JB
Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
[TBL] [Abstract][Full Text] [Related]
18. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
Huang Z; Elankumaran S; Yunus AS; Samal SK
J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
[TBL] [Abstract][Full Text] [Related]
19. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
[TBL] [Abstract][Full Text] [Related]
20. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response.
DiNapoli JM; Yang L; Samal SK; Murphy BR; Collins PL; Bukreyev A
Vaccine; 2010 Dec; 29(1):17-25. PubMed ID: 21034822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
